LEE MICHELLE SAARINAS: Open Payments
NPI 1932864188 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,039 in 26 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,039
Food & beverage: $1,039
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 4 | $194 |
| AstraZeneca Pharmaceuticals LP | 5 | $184 |
| Lilly USA, LLC | 2 | $152 |
| Amgen Inc. | 2 | $137 |
| Cleerly, Inc. | 2 | $101 |
| HARMONY BIOSCIENCES LLC | 2 | $85 |
| Lundbeck LLC | 3 | $66 |
| Azurity Pharmaceuticals, Inc. | 1 | $30 |
| PFIZER INC. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: VOQUEZNA, AIRSUPRA, MOUNJARO, Repatha, Cleerly Ischemia, WAKIX, REXULTI, EDARBI.
Industry payments across CA — which companies pay providers there.
